ArticleFrontiers in public health2025
Unintended pregnancies: a comprehensive cost-benefit analysis of family planning investment in Pakistan.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Understanding contraceptive use in Pakistan: The role of individual and community contextual factors.PloS one · 2026Article
- Factors associated with unmet need for family planning among adolescent and young married women in Pakistan.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Unintended pregnancies, which account for 19.4 to 38.2% of all births, present a significant and pressing public health challenge in Pakistan. Beyond the adverse effects of women's agency and choice, unsafe abortions, delayed prenatal care, and poor maternal health, they impose substantial economic costs on essential services such as education, healthcare, water, sanitation, and housing infrastructure. We quantified the economic cost of unintended pregnancies and the benefits of investing in family planning. Our findings directly challenge the rationale behind population-based revenue distribution formulas and provide compelling economic evidence for increased family planning budget allocations at both national and provincial levels. Methodology: This secondary data analysis employs a rigorous methodology, triangulating data from various national and international sources to conduct a comprehensive cost-benefit analysis. Using trend analysis with linear extrapolation, the study projects the economic impact of unintended pregnancies from 2018 to 2035 across key domains, such as schooling, immunization, safe motherhood, and access to safe water and sanitation. Key variables include contraceptive prevalence rate, unmet need for family planning, general fertility rate, under-five mortality rates, social costs per child, school enrollment rates, and per-user cost of family planning. Results: Our analysis reveals that the additional programming costs in health, education, and water provision from unintended pregnancies outweigh the investment required for family planning interventions aimed at averting them. Specifically, for every dollar invested in family planning, there is an estimated return of approximately USD $23 in combined cost savings. Education costs represent the largest proportion (51%) of these savings, followed by safe motherhood costs (36%), immunization costs (11%), and water/sanitation costs (2%). Conclusion: We show substantial cost savings from investing in family planning. Some provincial governments have argued that since national revenue distribution is population-based, they would lose funds if they instituted FP programs. We show that these losses are in a few percentage points while their cost savings in social programs would be in hundreds of percentage points while achieving healthier and flourishing populations. Cost-benefit analysis is a powerful tool for policymakers and may be institutionalized in health, population, planning, and finance ministries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.